✦ LIBER ✦

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

✍ Scribed by Rao, S; Starling, N; Cunningham, D; Benson, M; Wotherspoon, A; Lüpfert, C; Kurek, R; Oates, J; Baselga, J; Hill, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of cediranib in combinatio

✍ Taroh Satoh; Yasuhide Yamada; Kei Muro; Hidetoshi Hayashi; Yasuhiro Shimada; Dai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Phase II study of capecitabine and cispl

✍ Yong Sang Hong; Jeeyun Lee; Sang Cheol Lee; In Gyu Hwang; Seong-Ho Choi; Jin-Seo 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 391 KB

Epirubicin, oxaliplatin, and capecitabin

✍ Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Fran 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 396 KB

PCN37 PRELIMINARY COST-CONSEQUENCE ANALY

✍ AM Horgan; J Knox; G Liu; PA Bradbury; C Sahi; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I study of sunitinib plus capecita

✍ Lee, K.-W.; Park, S. R.; Oh, D.-Y.; Park, Y.-I.; Khosravan, R.; Lin, X.; Lee, S. 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 219 KB